Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Norovirus Hijacks NINJ1 for Selective NS1 Protein Secretion
2026-06-11
Song et al. reveal that murine norovirus (MNoV) exploits the host cell death effector NINJ1 to selectively secrete its NS1 protein, distinguishing this process from nonspecific DAMP release. This mechanistic insight redefines how viruses can manipulate programmed cell death pathways for targeted protein export, with implications for host-pathogen interaction and regulated secretion research.
-
Psora 4 (SKU B7659): Reliable Kv1.3 Blocker for Immune Cell
2026-06-11
This article provides a practical, scenario-driven guide for using Psora 4 (SKU B7659) as a selective Kv1.3 blocker in immune cell research. Drawing on published data and real lab challenges, it details how Psora 4 enhances assay reproducibility, selectivity, and workflow efficiency for advanced T cell and glomerulonephritis models.
-
SB743921: Precision Targeting of KSP in Cancer Drug Response
2026-06-10
Explore how SB743921, a leading kinesin spindle protein inhibitor, enables advanced, quantitative assessment of anti-proliferative mechanisms in cancer research. This article delivers unique, actionable insights for next-generation in vitro drug response assays.
-
A-769662 in Context: AMPK Activation, Autophagy, and Metabol
2026-06-10
Explore how A-769662, a potent AMPK activator, is reshaping our understanding of energy metabolism and autophagy regulation. This in-depth analysis uniquely examines the nuanced, context-dependent effects of AMPK activation—grounded in the latest research—to inform advanced metabolic and cell cycle studies.
-
Prestained Protein Marker (Triple Color): Advanced Assay Str
2026-06-09
Explore the scientific rationale and advanced application strategies for the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) in SDS-PAGE and Western blot workflows. This article offers a deep dive into performance, compatibility, and selection criteria for optimal protein analysis.
-
HotStart 2X Green qPCR Master Mix: Precision in Gene Express
2026-06-09
Unlock the full power of SYBR Green qPCR with HotStart™ 2X Green qPCR Master Mix, engineered for superior specificity and reproducibility in even the most demanding genetic screens. This guide distills bench-proven workflows, troubleshooting strategies, and advanced applications for researchers seeking robust gene expression data in target deconvolution and beyond.
-
Optimizing Cancer Assays with EZ Cap™ Human PTEN mRNA (ψUTP)
2026-06-08
This article unpacks how EZ Cap™ Human PTEN mRNA (ψUTP) (SKU R1026) addresses key laboratory hurdles in cell viability, proliferation, and pathway inhibition assays. Drawing from peer-reviewed evidence and validated protocols, we explore its reproducibility, stability, and immunogenicity profile, giving biomedical researchers actionable guidance for robust PI3K/Akt pathway studies.
-
Dinaciclib (SCH727965): Advanced Insights into CDK Inhibitio
2026-06-08
Explore how Dinaciclib (SCH727965), a potent CDK inhibitor, uniquely informs cancer research by linking cell cycle arrest with the biophysics of tissue boundary maintenance. This article provides advanced, actionable perspectives beyond standard workflows.
-
Dextrose (D-glucose) in Tumor Immunometabolism: Protocols an
2026-06-07
Explore how Dextrose (D-glucose) empowers advanced immunometabolic research, with a focus on hypoxia-driven tumor microenvironments. This article delivers protocol guidance and strategic analysis for leveraging APExBIO's D-glucose in cutting-edge cellular metabolism studies.
-
ARCA EGFP mRNA: Optimizing Fluorescence-Based Transfection A
2026-06-06
ARCA EGFP mRNA sets a new benchmark for directly quantifying transfection efficiency and gene expression in mammalian cells, thanks to its advanced capping and stability features. This guide offers actionable workflows, troubleshooting, and contextualizes cutting-edge delivery advances for researchers seeking reliable, robust fluorescence-based assays.
-
Targeted mRNA Nanoparticles Restore BBB Function After Strok
2026-06-05
This study introduces an M2 microglia-targeted lipid nanoparticle system for delivering therapeutic mRNA to ischemic brain regions, demonstrating restoration of the blood–brain barrier and improved neurological outcomes after stroke. The findings highlight the potential of precise, cell-selective mRNA delivery to modulate post-injury neuroinflammation and repair CNS damage.
-
n-Dodecyl-β-D-maltoside: Essential Detergent for Membrane Pr
2026-06-05
n-Dodecyl-β-D-maltoside (DDM) is a non-ionic detergent widely used for membrane protein purification and stabilization. Its unique micelle-forming properties enable gentle solubilization of hydrophobic proteins, preserving structural integrity for functional and structural studies. DDM is a cornerstone reagent in cryo-EM workflows and integrin research.
-
AZ505, a Potent SMYD2 Inhibitor: Validated Solutions for Epi
2026-06-04
This in-depth guide explores how AZ505 (SKU B1255), a potent and selective SMYD2 inhibitor, addresses practical challenges in cell-based epigenetic and cancer biology research. Through scenario-driven Q&A, we analyze workflow improvements, data reliability, and real-world protocol integration, with direct reference to primary literature and supplier documentation.
-
Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial U
2026-06-04
Temafloxacin stands out as a fluoroquinolone broad-spectrum antibacterial agent, offering robust activity against Gram-positive and Gram-negative respiratory pathogens and intracellular bacteria. Streamlined protocols, in vitro versatility, and unique pharmacokinetic properties allow Temafloxacin to power both standard and advanced infection research models with high reproducibility.
-
Streptavidin-Cy3: High-Affinity Fluorescent Biotin Detection
2026-06-03
Streptavidin-Cy3 is a robust fluorescent biotin detection reagent that combines high-affinity streptavidin with the Cy3 fluorophore for sensitive and specific labeling across diverse applications. Its 52.8 kDa tetrameric structure enables simultaneous binding of four biotin molecules, supporting multiplexed immunohistochemistry, immunofluorescence, in situ hybridization, and flow cytometry. The K1079 kit from APExBIO provides consistent performance and workflow reliability for advanced research protocols.